pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·Sep 21·1 min read
save

Singapore’s Health Sciences Authority expands regulatory partnerships across Africa, Asia and Europe

Sep 21, 2026·read at raps ↗RegulatoryNeutral

Singapore’s Health Sciences Authority (HSA) announced that it is broadening its regulatory reliance and cooperation framework.

The agency is establishing new alliances with regulatory bodies in several African, Asian and European nations, aiming to streamline product approvals and share expertise.

These collaborations are intended to facilitate faster access to health products across regions while maintaining safety standards.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Asia-Pacific Roundup: Singapore’s HSA forges regulatory alliances across Africa, Asia, and Europe”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoRecon: Sino, Boehringer ink cancer drug deal worth $7B; CVS to split pharmacy business from insuranceraps
  • 1d agoEuro Roundup: MDCG shares guidance on clinical evidence for orphan in vitro diagnosticsraps
  • 1d agoFDA official expects user fee reauthorization despite midterm shakeupraps
  • 2d agoFDA official urges sponsors to use alternatives to clinical efficacy studies for biosimilarsraps
  • 2d agoAI won’t erase jobs, but regulatory professionals need to be vigilant, experts sayraps